The disclosure includes high purity compounds having CCR5 and/or CCR2 antagonism, or salts thereof, high purity intermediates thereto and processes for synthesizing the same.

Disclosed are a reduction method and reduction product of an alkenyl active methylene compound. The reduction reaction comprises the following steps: taking an alkenyl active methylene compound as a substrate, a metal hydride as a reducing agent, and a palladium compound as a catalyst, performing a reduction reaction to obtain a reduction product, and then reducing the alkenyl active methylene compound. The reduction system is a simple method for reducing the alkenyl active methylene compound, and the used hydride and palladium compound catalyst are both reagents that could easily be obtained in a laboratory. Compared with conventional hydrogen hydrogenation methods and reduction methods of reducing agents, the method is easier to operate, higher in safety, mild in conditions, and high in reaction yield, a reaction in a one-pot two-step manner can be achieved, and high atom economy and step economy can be obtained.

A catalyst system has been designed that disrupts the sedimentation process. The catalyst system achieves this by saturating key feed components before the feed components are stripped into their incompatible aromatic cores. The efficacy of this disruptive catalyst system is particularly evident in a hydrocracker configuration that runs in two-stage-recycle operation. The catalyst is a self-supported multi-metallic catalyst prepared from a precursor in the hydroxide form, and the catalyst must be toward the top level of the second stage of the two-stage system.

The present disclosure belongs to the technical field of indomethacin synthesis, and discloses a method for synthesizing an indomethacin and an analogue thereof. The method for synthesizing an indomethacin and an analogue thereof includes steps of: introducing an alkyl group, an aromatic ring or a heteroaromatic ring directly at the C2 position of indole, a carboxylic acid fragment at the C3 position of the indole, and an aroyl group at the N1 position of the indole through palladium-catalyzed reactions. The present disclosure solves a problem: most of the existing indomethacin synthesis methods are achieved by construction of an indole ring and modification; simple structural changes of an indomethacin molecule based on this synthetic strategy often require de novo synthesis; the late modification and structure-activity relationship study of the indomethacin molecule have lengthy synthetic steps.

A new metal organic framework (MOF) series and method of synthesizing the same are disclosed which includes an organic linking ligand having the formula:

##STR00001##

and a metal ion bonded to the organic linking ligand.

The invention discloses a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst, a preparation method and use thereof. The preparation method comprises the steps of: dissolving an organic ligand and Ti(OC.sub.3H.sub.7).sub.4 in a mixture of methanol and DMF at a certain ratio, performing a hydrothermal reaction, centrifuging and drying to obtain a Titanium-based metal organic framework (Ti-MOF); pyrolyzing the obtained Ti-MOF under an inert atmosphere, and oxidizing the same for etching to obtain a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst. The obtained composite photocatalyst not only facilitates the adsorption, enrichment and mass transfer of low concentration VOCs, but also efficiently degrades VOCs under sunlight. It has high degradation activity and stability when performing photocatalytic removal of VOCs in the presence of visible light, is simple in synthesis, low in preparation cost, and has strong potential for the use in environmental protection.

Disclosed herein is a class of chiral binuclear metal complexes for stereoselective hydrolysis of saccharides and glycosides, and more particular chiral binuclear transition metal complex catalysts that discriminate epimeric glycosides and α- and β-glycosidic bonds of saccharides in aqueous solutions at near physiological pHs. The chiral binuclear metal complexes include a Schiff-base-type ligand derived from a chiral diamino building block, and a binuclear transition metal core, each which can be varied for selectivity. The metal core is a Lewis-acidic metal ion, such as copper, zinc, lanthanum, iron and nickel. The Schiff-base may be a reduced or non-reduced Schiff-base derived from aliphatic linear, aliphatic cyclic diamino alcohols or aromatic aldehydes. The ligand can be a penta- or heptadentate ligand derived from pyridinecarbaldehydes, benzaldehydes, linear or cyclic diamines or diamino alcohols.

In some embodiments, a metal-organic framework material includes tricarboxylate metal-organic frameworks. The tricarboxylate metal-organic frameworks include unmodified tricarboxylate ligands and modified tricarboxylate ligands. The modified tricarboxylate ligands are unmodified tricarboxylate ligand modified with aliphatic carbon chains. Methods of forming metal-organic framework materials and textiles containing modified metal-organic framework materials are also provided.

Novel crystalline porous materials known as metal-organic frameworks (MOFs) and methods for their synthesis are provided herein. The MOFs include a M.sub.6(μ.sub.3-OH).sub.8(OH).sub.8(μ.sup.2,η.sup.2-(O.sub.2C).sub.2cyclam).sub.8 cluster, and a metal atom coordinated to the one or more cyclam of the cluster, wherein M is Zr or Hf, and the metal atom is any one of Cu, Ni, Cr, Ru, Co, and Gd. The MOFs can be used as an adsorbent, alone or in a medium with other components, of CO.sub.2. The MOFs can also be used as a catalyst for the transformation of CO.sub.2 and epoxides to cyclic carbonates. The MOFs can also be used in the electrochemical catalytic reduction of CO.sub.2. The MOFs can also be used for photocatalytic CO.sub.2 reduction for the production of carbon-based fossil fuels. The MOFs can also be used for light-induced nitric oxide (NO) release. The MOFs can also be used as magnetic resonance imaging (MRI) agents.

A catalyst system has been designed that disrupts the sedimentation process. The catalyst system achieves this by saturating key feed components before the feed components are stripped into their incompatible aromatic cores. The efficacy of this disruptive catalyst system is particularly evident in a hydrocracker configuration that runs in two-stage-recycle operation. The catalyst is a self-supported multi-metallic catalyst prepared from a precursor in the hydroxide form, and the catalyst must be toward the top level of the second stage of the two-stage system.